Every Form 4 that Modular Medical, Inc. (MODD) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow MODD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MODD filings page.
Modular Medical, Inc. director Steven G. Felsher acquired 25 common shares under the company’s Outside Director Compensation Plan on September 30, 2026; his reported direct common-share position afterward was 8,538 shares, reflecting the 1-for-30 reverse stock split effected March 31, 2026. He also received an option for 250 shares, fully vested and exercisable on the grant date at a $1.95 exercise price and expiring September 30, 2036; the reported post-grant total for that derivative-security class was 250 options.
Modular Medical, Inc. (MODD) issued director Duane M. DeSisto 83 shares of common stock on September 30, 2026, under its Outside Director Compensation Plan. His direct holdings following the award were 9,412 shares. The reported share amount reflects the impact of a 1-for-30 reverse stock split effected March 31, 2026.
Modular Medical, Inc. director Carmen B. Volkart received an award of 108 common shares on September 30, 2026, under the Outside Director Compensation Plan. Her directly held position after the award was 1,036 shares; this post-transaction amount reflects the impact of the 1-for-30 reverse stock split effected March 31, 2026.
Modular Medical, Inc. granted director Jeff D. Goldberg 250 options to purchase common stock on September 30, 2026, covering 250 common shares. The options were fully vested and exercisable on the grant date, have a $1.95 exercise price, and expire September 30, 2036. The reported post-transaction position was 250 options in that derivative-security class.
Modular Medical, Inc. (MODD) director Ellen O'Connor Vos received a grant of 250 options to purchase common stock on September 30, 2026. The options were fully vested and exercisable on the grant date, at an exercise price of $1.95 per share. The reported post-grant position in this option class was 250 options.
Modular Medical, Inc. director Philip Brent Sheibley received a grant of an option to purchase 250 shares of common stock on September 30, 2026. The option was fully vested and exercisable on the grant date, has an exercise price of $1.95 per share, and expires September 30, 2036.
Modular Medical, Inc. director and 10% owner Morgan C. Frank received two grants of options to purchase common stock on September 30, 2026: 62 options and 250 options, each with an exercise price of $1.95. The options were granted under the company's Outside Director Compensation Plan.
Modular Medical, Inc. director Ellen O'Connor Vos received a grant of options to purchase 250 shares of common stock at an exercise price of $4.88 per share. The options were granted under the Outside Director Compensation Plan, were fully vested and exercisable on the grant date, and expire on June 30, 2036.
Modular Medical, Inc. director Philip Brent Sheibley received an option grant covering 250 shares of common stock. The option was granted under the company’s Outside Director Compensation Plan, is fully vested, and became exercisable on the grant date at an exercise price of $4.88 per share.
Modular Medical, Inc. director Jeff D. Goldberg received an option grant to purchase 250 shares of common stock. The option was awarded on June 30, 2026 under the company’s Outside Director Compensation Plan, with an exercise price of $4.88 per share, and was fully vested and exercisable on the grant date. The option for 250 underlying common shares expires on June 30, 2036, and represents his reported beneficial ownership of this class of derivative security following the transaction.
Modular Medical, Inc. director Steven G. Felsher received equity compensation consisting of common shares and stock options. He was granted 25 shares of common stock at a stated price of $0.0000 per share under the company’s Outside Director Compensation Plan, bringing his direct common stock holdings to 8,498 shares.
He was also granted an option to purchase 250 shares of common stock at an exercise price of $4.88 per share, expiring on June 30, 2036. The option was fully vested and exercisable on the grant date. Share amounts reflect a 1-for-30 reverse stock split of the company’s common stock effected on March 31, 2026.
Modular Medical, Inc. director Carmen B. Volkart received a grant of common stock as part of board compensation. On the reported date, Volkart acquired 110 shares of common stock at a price of $0.00 per share, increasing direct holdings to 916 shares. The shares were issued under the company’s Outside Director Compensation Plan, and the reported share amounts reflect the impact of a 1-for-30 reverse stock split of the common stock that was effected on March 31, 2026.
Modular Medical, Inc. director Duane M. DeSisto received a grant of common stock under the company’s Outside Director Compensation Plan. He acquired 83 shares at a price of $0.00 per share and now directly holds 8,627 common shares. A 1-for-30 reverse stock split on March 31, 2026 affected the reported share amounts.
Modular Medical, Inc. director and 10% owner C. Frank Morgan received new stock option awards as part of his outside director compensation. On June 30, 2026, he was granted options for 250 shares of common stock and a separate grant for 62 shares, each with an exercise price of $4.88 per share. The footnotes state these options were granted under the company’s Outside Director Compensation Plan and were fully vested and exercisable on the grant date. Following the grants, his reported beneficial ownership for these option classes is 312 options for one class and 62 options for the other.
Modular Medical, Inc. reported that company officer Paul DiPerna received a grant of stock options as part of his compensation. He was awarded options to purchase 11,218 shares of common stock at an exercise price of $3.46 per share, expiring on May 14, 2036. One third of the options will vest on May 14, 2027, with the remaining portion vesting in equal monthly installments over the following 36 months. After this grant, DiPerna holds 11,218 options of this class directly.
Modular Medical, Inc. reported that its Chief Operating Officer, Kevin Schmid, received a grant of options to purchase 4,674 shares of common stock. The options have an exercise price of $3.46 per share and expire on May 14, 2036.
According to the grant terms, one-third of the option shares will vest on May 14, 2027, with the remaining shares vesting in equal monthly installments of 1/36th thereafter. Following this grant, Schmid holds 4,674 options of this derivative security directly.
Modular Medical, Inc. director and ten percent owner C. Frank Morgan received fully vested options to purchase an additional 312 shares of common stock as compensation. The awards consist of options for 62 shares and 250 shares, each with an exercise price of $4.55 per share, granted under the company’s Outside Director Compensation Plan.
Modular Medical, Inc. director Ellen O'Connor Vos received a grant of options to purchase 250 shares of common stock. The options have an exercise price of $4.55 per share, were fully vested and exercisable on the March 31, 2026 grant date, and expire on March 31, 2036. After this award, she beneficially owns 250 options of this class of derivative security.
Modular Medical, Inc. director Jeff D. Goldberg received an option grant for 250 shares of common stock on March 31, 2026. The option has an exercise price of $4.55 per share, was granted under the company’s Outside Director Compensation Plan, and was fully vested and exercisable on the grant date. Following this grant, he beneficially owns 250 derivative securities of this option class.
Modular Medical, Inc. director Philip Brent Sheibley received an option grant to purchase 250 shares of common stock on the company’s stock. The option has an exercise price of $4.55 per share, was granted under the company’s Outside Director Compensation Plan, and was fully vested and exercisable on the grant date.
Following the grant, Sheibley beneficially owns 250 options of this class of derivative security, according to the Form 4.
Modular Medical, Inc. director Steven G. Felsher reported compensation-related equity awards. He received an option to purchase 250 shares of common stock at an exercise price of $4.55 per share, fully vested and exercisable on the grant date, under the Outside Director Compensation Plan. He was also granted 25 shares of common stock with no purchase price. After this grant, he directly owns 8,473 shares of common stock. The reported share amounts reflect the impact of a 1-for-30 reverse stock split effective March 31, 2026.
DeSisto Duane M reported acquisition or exercise transactions in this Form 4 filing.
Modular Medical, Inc. director Duane M. DeSisto received a grant of 83 shares of common stock on March 31, 2026 as compensation under the company’s Outside Director Compensation Plan. The grant was at no cash cost per share and brought his directly held stake to 8,544 shares.
A 1-for-30 reverse stock split of Modular Medical’s common stock, effective March 31, 2026, is reflected in the reported share amounts, meaning both the grant and total holdings are shown on a post-split basis.
Volkart Carmen B reported acquisition or exercise transactions in this Form 4 filing.
Modular Medical, Inc. director Carmen B. Volkart received a grant of 103 shares of Common Stock on March 31, 2026 as a compensation award. The shares were issued under the company’s Outside Director Compensation Plan and brought Volkart’s direct holdings to 806 shares. The share amounts reflect a 1-for-30 reverse stock split of the common stock that was effected on the same date.
Modular Medical director Steven Felsher reported buying 60,000 shares of the company’s common stock in an underwritten public offering on December 11, 2025. The transaction was coded as an acquisition, and his directly held common stock increased to 253,177 shares after the purchase.
Felsher also acquired warrants to purchase 30,000 shares of common stock at an exercise price of $0.45 per share. These warrants were immediately exercisable on December 11, 2025 and expire on December 11, 2030. The offering price was $0.77 for each combination of two shares of common stock and one warrant, and his total beneficial ownership of this warrant class is 30,000 warrants.
Modular Medical, Inc. director Philip Sheibley reported buying company securities in an underwritten public offering. On December 11, 2025 he acquired 22,000 shares of common stock, bringing his direct holdings to 97,513 shares. He also acquired warrants with a $0.45 exercise price covering 11,000 shares of common stock, which are immediately exercisable and expire on December 11, 2030, resulting in 11,000 derivative securities held. The filing further notes that on the same date he purchased 60,000 shares of common stock and warrants to buy 30,000 shares at an offering price of $0.77 for each two shares of common stock and one warrant.